Valvular Heart Disease Clinical Trials

31 recruiting

Valvular Heart Disease Trials at a Glance

34 actively recruiting trials for valvular heart disease are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in London, New York, and Hangzhou. Lead sponsors running valvular heart disease studies include Abbott Medical Devices, LMU Klinikum, and Second Affiliated Hospital, School of Medicine, Zhejiang University.

Browse valvular heart disease trials by phase

Treatments under study

About Valvular Heart Disease Clinical Trials

Looking for clinical trials for Valvular Heart Disease? There are currently 31 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Valvular Heart Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Valvular Heart Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 34 trials

Recruiting

DELINEATE-Prospective

Valvular Heart DiseaseValve Disease, AorticAortic Stenosis+2 more
Columbia University50 enrolled1 locationNCT07197736
Recruiting

Abbott Structural Heart Device Registry

Heart DiseasesValvular Heart DiseasePFO - Patent Foramen Ovale+3 more
Abbott Medical Devices2,500 enrolled28 locationsNCT06590467
Recruiting
Not Applicable

Robotic Transjugular Transcatheter Tricuspid Valve Replacement

Tricuspid Regurgitation (TR)Transcatheter Valve ReplacementValvular Heart Diseases
Prince of Wales Hospital, Shatin, Hong Kong10 enrolled1 locationNCT07516145
Recruiting

Prospective Evaluation of AI-ECG for SHD Detection

Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)Pulmonary Hypertension (Diagnosis)+1 more
Imperial College London590 enrolled5 locationsNCT07057466
Recruiting
Phase 2Phase 3

Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)

Pulmonary HypertensionRheumatic Valvular Heart Disease
Sindh Institute of Cardiovascular Diseases100 enrolled1 locationNCT07462260
Recruiting

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

CardiomyopathiesValvular Heart DiseasePericardial Disease
Tulane University500 enrolled3 locationsNCT04843371
Recruiting
Not Applicable

Optimized Expansion of the Implanted Transcatheter Aortic Valve

Valvular Heart DiseaseAortic Stenosis Disease
Ole De Backer620 enrolled10 locationsNCT07042529
Recruiting

In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm

Heart FailureValvular Heart DiseaseMitral Regurgitation
Inova Health Care Services50 enrolled1 locationNCT06675448
Recruiting

Mechanism and Effect of Novel Metabolites on Valvular Heart Disease

Valvular Heart Disease
Sun Yat-sen University4,000 enrolled1 locationNCT07065500
Recruiting
Not Applicable

Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions

Valvular Heart Disease
Vanderbilt University Medical Center375 enrolled1 locationNCT06077201
Recruiting
Not Applicable

Comparing Measurements of the Aortic Valve Taken During Surgery With Those Obtained Before Surgery Using Computed Tomography Scans, in Patients Undergoing Surgical Aortic Valve Replacement

Valvular Heart Disease
Maria Cecilia Hospital82 enrolled1 locationNCT07125469
Recruiting

Screening of Valvular Heart Disease Using Single-channel Electrocardiogram

Valvular Heart DiseaseValvular Heart Disease Stenosis and Regurgitation
I.M. Sechenov First Moscow State Medical University1,200 enrolled1 locationNCT07099417
Recruiting

Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Tricuspid RegurgitationValvular Heart DiseaseMitral Regurgitation
Abbott Medical Devices550 enrolled17 locationsNCT04761120
Recruiting
Not Applicable

The VALVE-AI Trial

Valvular Heart Disease Patients
National Defense Medical Center, Taiwan8,648 enrolled1 locationNCT07023510
Recruiting

Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment

Heart FailureHypertensionDiabetes+2 more
HJN Sverige AB/Neko Health8,000 enrolled3 locationsNCT06984211
Recruiting

Evaluation of Valvular Heart Disease Using Cardiac CT

Valvular Heart Disease
Toho University350 enrolled1 locationNCT06937125
Recruiting

Development of CIRC Technologies

Heart FailureCardiovascular DiseasesAtrial Fibrillation+7 more
The Cleveland Clinic1,000 enrolled1 locationNCT05654272
Recruiting
Not Applicable

Study on Optimal Temperature During Cardiopulmonary Bypass (THERMIC-4)

Cardiovascular DiseasesValvular Heart DiseaseIschemic Heart Disease
University of Leicester100 enrolled11 locationsNCT05996120
Recruiting

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Heart FailureCardiotoxicityMyocardial Infarction+12 more
Peerbridge Health, Inc1,500 enrolled8 locationsNCT06699056
Recruiting

PANDA Trial - Physical activity in Nature for Cardiometabolic Diseases in People Aged 45y+

Stable Cerebrovascular DiseaseDiabetes MellitusHypertension+4 more
University of New South Wales254 enrolled1 locationACTRN12624001450505